AMGEN INC — Director's Dealing 2017

Jun 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2017-05-31

Reporting Person: BALTIMORE DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-31	Common Stock	S	3700	$153.93	Disposed	31159	Direct